Aved products recall: No market authorization
Brand(s)
Last updated
Summary
Product
Various Ophthalmic Solutions from Aved
Issue
Health products - Unauthorized product
What to do
Consult your health care professional if you have any health concerns.
Distribution
National
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot Number |
|---|---|---|---|---|---|
| Labtician Ophthalmics, Inc. / Aved | Atropine Sulfate 0.01% Ophthalmic Solution, 5 mL | No market authorization | Solution | Atropine Sulfate 0.01% | 11122025@5, 01052026@11 |
| Labtician Ophthalmics, Inc. / Aved | Atropine Sulfate 0.02% Ophthalmic Solution, 5 mL | No market authorization | Solution | Atropine Sulfate 0.02% | 10162025@3, 12052025@5, 01272026@13 |
| Labtician Ophthalmics, Inc. / Aved | Atropine Sulfate 0.025% Ophthalmic Solution, 5 mL | No market authorization | Solution | Atropine Sulfate 0.025% | 10162025@5, 12082025@12, 01272026@14, 02252026@5 |
| Labtician Ophthalmics, Inc. / Aved | Atropine Sulfate 0.05% Ophthalmic Solution, 5 mL | No market authorization | Solution | Atropine Sulfate 0.05% | 10022025@3, 11202025@8, 01152026@6, 02042026@14 |
| Labtician Ophthalmics, Inc. / Aved | Fluorescein Na 0.25% / Proparacaine HCl 0.5% Ophthalmic Solution, 5 mL | No market authorization | Solution | Fluorescein Na 0.25% / Proparacaine HCl 0.5% | 11202025@5, 12082025@11, 12232025@2, 01212026@10 |
| Labtician Ophthalmics, Inc. / Aved | Insulin Regular (Human) 25 IU/mL Ophthalmic Solution, 10 mL | No market authorization | Solution | Insulin 25 IU/mL | 10232025@3, 11142025@4, 12112025@3, 01222026@8 |
| Labtician Ophthalmics, Inc. / Aved | Mitomycin 0.04% Ophthalmic Solution (PF), 0.75 mL | No market authorization | Solution | Mitomycin 0.04% | 01192026@8 |
| Labtician Ophthalmics, Inc. / Aved | Moxifloxacin HCl 150 mcg/0.1 mL Ophthalmic Injection Solution, 0.75 mL | No market authorization | Solution | Moxifloxacin HCl 150 mcg/0.1 mL | 01192026@8 |
| Labtician Ophthalmics, Inc. / Aved | Prednisolone Sodium Phosphate 1% / Moxifloxacin 0.5% / Bromfenac 0.075% | No market authorization | Solution | Prednisolone Sodium Phosphate 1%/Moxifloxacin 0.5%/Bromfenac 0.075% | 12162026@11 |
Issue
Products sold without market authorization (DIN) in Canada due to third-party branding.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers, Health Care Establishments
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Aved
44 Richmond St. West, Unit 202,
Oshawa, Ontario, L1G 1C7
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type III
Identification number
RA-81839
Get notified
Receive emails about new and updated recall and safety alerts.